Search
for
Sort by
Research 121–150 of 1000+
- Novel therapies for alopecia areata: The era of rational drug development
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Tolerability of hair cleansing conditioners: a double-blind randomized, controlled trial designed to evaluate consumer complaints to the U.S. Food and Drug Administration
- Drug-induced alopecia after dupilumab therapy
- PD29-07 DRUGS ASSOCIATED THE MOST WITH MALE-FACTOR INFERTILITY: ASSESSMENT OF THE 2010-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE
- Cutaneous lupus erythematosus
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
- 006 Exogenous IL-27 promotes immunosuppressive T cells and prevents the development of alopecia areata in C3H/HeJ mice
- Alopecia Areata in 12 years old female treated with Oral Azathioprine: A case report and review
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Follicular dystrophy of immunosuppression
- Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
- Scalp Sarcoidosis with Systemic Involvement: A Case Report and Literature Review
- Dermatologic Care of the Transplant Patient
- The role of fractional laser‐assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra‐patient comparative randomized clinical trial
- Fever and rash as initial signs of systemic autoimmune disease. Case Report.
- Alopecia Areata
- Lupus erythematosus: systemic and cutaneous manifestations
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Immunosuppressive treatment for proliferative lupus nephritis
- Cyclosporin A: a new drug in the field of canine dermatology
- Effect of physical stimuli on hair follicle deposition of clobetasol-loaded Lipid Nanocarriers
- Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
- Microneedle-Based Approaches for Skin Disease Treatment
- Herbal nano-formulations for topical delivery